Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
StockCIK 818686

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Insider Trades and Fund Holdings

In the past 12 months, TEVA PHARMACEUTICAL INDUSTRIES LTD insiders reported 0 open-market purchases worth $0 and 5 sales worth $15.7M; 1 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$15.7MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.

  1. Sep 21, 2026Planned saleSavage Brian (officer, chief legal officer) filed notice to sell about $273,062 around Sep 18, 2026
  2. Sep 18, 2026Insider saleDirector Roberto Mignone sold $14.4 million (2 days after: signed a material agreement)
  3. Sep 18, 2026Insider saleGeneral Counsel Brian Savage sold $285,215 (2 days after: signed a material agreement)
  4. Sep 18, 2026Planned saleBridger Management, LLC (1) (shareholder) filed notice to sell about $14.4 million around Sep 18, 2026
  5. Sep 16, 2026NewsCompany reported: Signed a material agreement
  6. Aug 21, 2026Insider saleCAO Amir Weiss sold $355,301
  7. Aug 21, 2026Insider saleDirector Ronit Satchi-Fainaro sold $15,459
  8. Aug 17, 2026Insider saleEVP Evan Lippman sold $680,291 under a 10b5-1 plan
  9. Jun 30, 2026FundBridgewater Associates added 18% in Q2 2026 (13F filed Aug 14, 2026)
  10. Jun 30, 2026FundDuquesne Family Office cut 74% in Q2 2026 (13F filed Aug 14, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 22, 2026.

Recent TEVA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Sep 22Sep 18Roberto MignoneDirectorDirector (ind.)▼ SELL367,60039.06$14.4MAll soldForm 4 ↗
Sep 22Sep 18Brian SavageGeneral CounselGeneral Counsel▼ SELL7,34238.85$285K−46%Form 4 ↗
Aug 25Aug 21Amir WeissCAOCAO▼ SELL9,44537.62$355K−42%Form 4 ↗
Aug 25Aug 21Ronit Satchi-FainaroDirectorDirector▼ SELL41537.25$15K−0.4%Form 4 ↗
Aug 19Aug 17Evan LippmanEVPEVP▼ SELL10b5-118,60036.57$680K−42%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Roberto MignoneDirector0$01$14.4MSep 22, 2026
Brian SavageGeneral Counsel0$01$285KSep 22, 2026
Amir WeissCAO0$01$355KAug 25, 2026
Ronit Satchi-FainaroDirector0$01$15KAug 25, 2026
Evan LippmanEVP0$01$680KAug 19, 2026

Tracked funds that report TEVA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Bridgewater AssociatesQ2 20261,326,678$44.9M0.18%▲ +17.6%
Duquesne Family OfficeQ2 2026624,999$21K0.49%▼ −73.7%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →